211 related articles for article (PubMed ID: 24021346)
1. Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
Hillman GG; Singh-Gupta V; Hoogstra DJ; Abernathy L; Rakowski J; Yunker CK; Rothstein SE; Sarkar FH; Gadgeel S; Konski AA; Lonardo F; Joiner MC
Radiother Oncol; 2013 Oct; 109(1):117-25. PubMed ID: 24021346
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury.
Hillman GG; Singh-Gupta V; Runyan L; Yunker CK; Rakowski JT; Sarkar FH; Miller S; Gadgeel SM; Sethi S; Joiner MC; Konski AA
Radiother Oncol; 2011 Nov; 101(2):329-36. PubMed ID: 22079530
[TBL] [Abstract][Full Text] [Related]
3. Radioprotection of lung tissue by soy isoflavones.
Hillman GG; Singh-Gupta V; Lonardo F; Hoogstra DJ; Abernathy LM; Yunker CK; Rothstein SE; Rakowski J; Sarkar FH; Gadgeel S; Konski AA; Joiner MC
J Thorac Oncol; 2013 Nov; 8(11):1356-64. PubMed ID: 24077456
[TBL] [Abstract][Full Text] [Related]
4. Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils.
Abernathy LM; Fountain MD; Rothstein SE; David JM; Yunker CK; Rakowski J; Lonardo F; Joiner MC; Hillman GG
J Thorac Oncol; 2015 Dec; 10(12):1703-12. PubMed ID: 26709479
[TBL] [Abstract][Full Text] [Related]
5. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
Hillman GG
Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
[TBL] [Abstract][Full Text] [Related]
6. Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury.
Fountain MD; McLellan LA; Smith NL; Loughery BF; Rakowski JT; Tse HY; Hillman GG
Int J Radiat Biol; 2020 Feb; 96(2):245-256. PubMed ID: 31633433
[No Abstract] [Full Text] [Related]
7. Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.
Fountain MD; Abernathy LM; Lonardo F; Rothstein SE; Dominello MM; Yunker CK; Chen W; Gadgeel S; Joiner MC; Hillman GG
Front Oncol; 2015; 5():238. PubMed ID: 26557504
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
11. Radiation injury to cardiac arteries and myocardium is reduced by soy isoflavones.
Dominello MM; Fountain MD; Rothstein SE; Cannon AC; Abernathy LM; Hoogstra D; Chen W; Joiner MC; Hillman GG
J Radiat Oncol; 2017 Sep; 6(3):307-315. PubMed ID: 31824587
[TBL] [Abstract][Full Text] [Related]
12. Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones.
Abernathy LM; Fountain MD; Joiner MC; Hillman GG
Front Oncol; 2017; 7():7. PubMed ID: 28168165
[TBL] [Abstract][Full Text] [Related]
13. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation.
Shi HS; Gao X; Li D; Zhang QW; Wang YS; Zheng Y; Cai LL; Zhong RM; Rui A; Li ZY; Zheng H; Chen XC; Chen LJ
Int J Nanomedicine; 2012; 7():2601-11. PubMed ID: 22679371
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Antonadou D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of prostate cancer by soy isoflavones.
Raffoul JJ; Sarkar FH; Hillman GG
Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
[TBL] [Abstract][Full Text] [Related]
16. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
[TBL] [Abstract][Full Text] [Related]
17. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
MartÃnez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract][Full Text] [Related]
18. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
[TBL] [Abstract][Full Text] [Related]
19. Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse.
Machtay M; Scherpereel A; Santiago J; Lee J; McDonough J; Kinniry P; Arguiri E; Shuvaev VV; Sun J; Cengel K; Solomides CC; Christofidou-Solomidou M
Radiother Oncol; 2006 Nov; 81(2):196-205. PubMed ID: 17069914
[TBL] [Abstract][Full Text] [Related]
20. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
